Advertisement
Advertisement
APYX
Apyx Medical Corporation Common Stock
2.39
USDSponsored
-0.10
-4.02%
Nov 19, 15:59 UTC -5
Closed
After-Market
2.36
-0.03
-1.21%
Apyx Medical Corporation Common Stock (APYX) Earnings
APYX Earnings Reports
Positive Surprise Ratio
APYX beat 31 of 44 last estimates.
70%
Next Report
Date of Next Report
Mar 08, 2027
Estimate for Q4 26 (Revenue/ EPS)
$19.57M
/-$0.04
Implied change from Q3 26 (Revenue/ EPS)
+39.51%
/--
Implied change from Q4 25 (Revenue/ EPS)
+2.14%
/+33.33%
Apyx Medical Corporation Common Stock earnings per share and revenue
On Nov 05, 2026, APYX reported earnings of -0.04 USD per share (EPS) for Q3 26, beating the estimate of -0.09 USD, resulting in a 57.98% surprise. Revenue reached 14.03 million, compared to an expected 13.56 million, with a 3.50% difference. The market reacted with a +18.15% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.04 USD, with revenue projected to reach 19.57 million USD, implying an increase of 0.00% EPS, and increase of 39.51% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Apyx Medical Corporation Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Apyx Medical Corporation Common Stock reported EPS of -$0.04, beating estimates by 57.98%, and revenue of $14.03M, 3.5% above expectations.
How did the market react to Apyx Medical Corporation Common Stock's Q3 2026 earnings?
The stock price moved up 18.15%, changed from $2.59 before the earnings release to $3.06 the day after.
When is Apyx Medical Corporation Common Stock expected to report next?
The next earning report is scheduled for Mar 08, 2027.
What are the forecasts for Apyx Medical Corporation Common Stock's next earnings report?
Based on --
analysts, Apyx Medical Corporation Common Stock is expected to report EPS of -$0.04 and revenue of $19.57M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.